Iterum Therapeutics
Iterum Therapeutics plc is a clinical-stage pharmaceutical company headquartered in Dublin, Ireland, focused on developing novel anti-infective medications to treat multi-drug resistant (MDR) bacterial infections. Its lead product, ORLYNVAH (sulopenem), is described as the first oral and IV penem antibiotic targeting gram-negative resistant infections. The company was surfaced as a portfolio company of canaan-partners and added to the API Evangelist network. Iterum Therapeutics is a pharmaceutical/biotech company and does not operate a public developer API; as of March 2026 the company entered liquidation following a High Court order in Ireland.
Iterum Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Pharmaceutical, Biotechnology, Anti-Infectives, and Antibiotics.
Iterum Therapeutics’ developer surface includes support and 4 more developer resources.
Kin Score
Resources
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API